Form 4 for AORT ARTIVION, INC.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001628280-25-053702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-24 | 2025-11-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $15.48 | +3,388 | 46.8K | +8% | +$52.4K |
| DM | 2025-11-24 | 2025-11-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.18 | -15.3K | 44.8K | -25% | -$674.8K |
| DM | 2025-11-24 | 2025-11-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $0.00 | -3,388 | 20.3K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | M | A | 1,355 | $11.03 | 46,108 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-20 | S | D | 1,355 | $44.28 | 44,753 | D | — | — | (F3) Reflects weighted average price. Range of prices were between $44.26 to $44.35. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-11-20 | S | D | 2,033 | $44.32 | 44,753 | D | — | — | (F2) Reflects weighted average price. Range of prices were between $44.26 to $44.44. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-11-20 | M | A | 2,033 | $18.44 | 46,786 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-20 | S | D | 11,888 | $44.14 | 44,753 | D | — | — | (F1) Reflects weighted average price. Range of prices were between $43.92 to $44.49. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Options (Right to buy) | 2025-11-20 | M | D | 1,355 | $0.00 | 27,075 | D | $11.03 · 2023-11-08 to 2029-11-08 | 1,355 Common Stock | (F5) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023. |
| 7 | Derivative | Stock Options (Right to buy) | 2025-11-20 | M | D | 2,033 | $0.00 | 20,301 | D | $18.44 · 2023-02-23 to 2029-02-23 | 2,033 Common Stock | (F4) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023. |